USFDA gives nod to Lupin’s generic formulation to treat eye issues

  • Posted on January 9, 2025
  • By Financial Express
  • 3 Views
USFDA gives nod to Lupin’s generic formulation to treat eye issues

Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sale of USD 36 million in the U.S. (IQVIA MAT November 2024)
continue reading...

Author
Financial Express

You May Also Like